Member-only story
ABBV-When Gann Met QQE
How a 12-Year Trade on AbbVie Beat the Market by 38%
Kryptera8 min read·Just now--
Disclaimer: The backtest results in this article are based solely on historical data and do not guarantee future performance. Anyone wishing to use this trading system should conduct their own research and testing before applying it.
The story of AbbVie is already remarkable on its own terms. Spun off from Abbott Laboratories in January 2013, ABBV began life trading just above $20. By the end of 2025 it had crossed $226 — a more than tenfold expansion over 13 years, funded by the monstrous commercial success of Humira, a pivot to Skyrizi and Rinvoq, and a series of acquisitions that redefined the company’s future. Buy-and-hold investors who held from day one would have seen their $100,000 grow to roughly $1.1 million, a 1,005% total return.
import pandas as pd
import numpy as np
import yfinance as yf
import vectorbt as vbt
# -------------------------
# Download Data
# -------------------------
symbol = "ABBV"
start_date = "2000-01-01"
end_date = "2026-01-01"
interval = "1d"
df = yf.download(symbol, start=start_date, end=end_date, interval=interval, multi_level_index=False)
df.to_csv("ABBV_clean.csv", index=False)
df